Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet ...
With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken ...
The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan ...
The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...
An Instagram ad catches your eye. You click to the product’s website and find reassurance: The product, it says, is "FDA certified" or was "produced in an FDA registered facility." Mention of the U.S.
The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...
Broadcast Retirement Network's Jeffrey Snyder discusses Over-the-Counter hearing aids with Towson University's Julie Norin, AuD. Jeffrey H. Snyder, Broadcast Retirement Network This morning on BRN, ...
The Food and Drug Administration is removing black box warnings from hormone replacement therapy products and approving new ...
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and ...
"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Could Trump destroy the Epstein files? New ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback